Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Hashimoto

Showing results (231-240 of 330) with videos related to

Pageof 33
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|May 24, 2021
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective studyTakuma Narita, Shingo Hatakeyama, Kazuyuki Numakura, et al.
Case Reports in Urology|March 22, 2014
A Case of Malignant Pheochromocytoma Detected during Fertility TreatmentKazuhisa Hagiwara, Itsuto Hamano, Ayumu Kusaka, et al.
Transplantation Proceedings|May 26, 2020
Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in JapanItsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, et al.
Transplantation Proceedings|May 26, 2020
Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal FunctionItsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, et al.
Cancer Research|July 3, 2004
Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancersKeiko Miyazaki, Katsuyuki Ohmori, Mineko Izawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 20, 2023
Trends in the age of hospitalized patients with urological cancers: A 17-year experienceNoritaka Ishii, Shingo Hatakeyama, Hikari Miura, et al.
Prostate International|March 25, 2024
Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective studyNaoki Fujita, Shingo Hatakeyama, Ryuji Tabata, et al.
Journal of Biochemistry|January 6, 2017
Excess APP O-glycosylation by GalNAc-T6 decreases Aβ productionKeiko Akasaka-Manya, Masaki Kawamura, Hiroki Tsumoto, et al.
Journal of Biochemistry|August 8, 2013
Lectin-dependent inhibition of antigen-antibody reaction: application for measuring α2,6-sialylated glycoforms of transferrinKyoka Hoshi, Yoshinobu Kariya, Kiyomitsu Nara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 10, 2020
STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasisKazutaka Okita, Shingo Hatakeyama, Atsushi Imai, et al.
Pageof 33

Showing results (231-240 of 330) with videos related to

Sort By:
Pageof 33
International Journal of Urology : Official Journal of the Japanese Urological Association|May 24, 2021
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective studyTakuma Narita, Shingo Hatakeyama, Kazuyuki Numakura, et al.
Case Reports in Urology|March 22, 2014
A Case of Malignant Pheochromocytoma Detected during Fertility TreatmentKazuhisa Hagiwara, Itsuto Hamano, Ayumu Kusaka, et al.
Transplantation Proceedings|May 26, 2020
Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in JapanItsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, et al.
Transplantation Proceedings|May 26, 2020
Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal FunctionItsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, et al.
Cancer Research|July 3, 2004
Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancersKeiko Miyazaki, Katsuyuki Ohmori, Mineko Izawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 20, 2023
Trends in the age of hospitalized patients with urological cancers: A 17-year experienceNoritaka Ishii, Shingo Hatakeyama, Hikari Miura, et al.
Prostate International|March 25, 2024
Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective studyNaoki Fujita, Shingo Hatakeyama, Ryuji Tabata, et al.
Journal of Biochemistry|January 6, 2017
Excess APP O-glycosylation by GalNAc-T6 decreases Aβ productionKeiko Akasaka-Manya, Masaki Kawamura, Hiroki Tsumoto, et al.
Journal of Biochemistry|August 8, 2013
Lectin-dependent inhibition of antigen-antibody reaction: application for measuring α2,6-sialylated glycoforms of transferrinKyoka Hoshi, Yoshinobu Kariya, Kiyomitsu Nara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 10, 2020
STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasisKazutaka Okita, Shingo Hatakeyama, Atsushi Imai, et al.
Pageof 33